[{"id":"5599ffaf-cdc8-45f1-ae66-e03729315e47","acronym":"","url":"https://clinicaltrials.gov/study/NCT00071981","created_at":"2021-01-18T00:11:04.801Z","updated_at":"2024-07-02T16:35:44.532Z","phase":"Phase 2","brief_title":"Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma","source_id_and_acronym":"NCT00071981","lead_sponsor":"Eastern Cooperative Oncology Group","biomarkers":" IFNG • IL2","pipe":"","alterations":" ","tags":["IFNG • IL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Leukine (sargramostim) • multi-epitope melanoma peptide"],"overall_status":"Completed","enrollment":" Enrollment 175","initiation":"Initiation: 05/09/2005","start_date":" 05/09/2005","primary_txt":" Primary completion: 08/01/2011","primary_completion_date":" 08/01/2011","study_txt":" Completion: 01/01/2014","study_completion_date":" 01/01/2014","last_update_posted":"2023-06-28"}]